KalVista Pharmaceuticals KALV
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 20.13 | -0.43 | -23,442 | -23 | ||
| 2025Q2 | 11.31 | 108.44 | -1.12 | -59,009 | -60 | |
| 2025Q1 | 11.54 | 109.76 | -0.99 | -55,030 | -52 | |
| 2024Q4 | 8.47 | 103.67 | -0.92 | -42,939 | -49 | |
| 2024Q3 | 11.58 | 108.38 | -0.91 | -45,811 | -42 | |
| 2024Q2 | 11.78 | 109.33 | -0.87 | -44,215 | -40 | |
| 2024Q1 | 11.86 | 108.52 | -1.07 | -48,455 | -45 | |
| 2023Q4 | 12.25 | 114.2 | -0.83 | -33,151 | -29 | |
| 2023Q3 | 9.63 | 107.58 | -0.8 | -29,746 | -28 | |
| 2023Q2 | 9 | 114.91 | -0.74 | -29,093 | -25 | |
| 2023Q1 | 7.86 | 120.62 | -0.75 | -31,728 | -26 | |
| 2022Q4 | 6.76 | 126.48 | -0.74 | -26,945 | -21 | |
| 2022Q3 | 14.51 | 116.29 | -0.9 | -25,882 | -22 | |
| 2022Q2 | 9.84 | 114.21 | -26,316 | -23 | ||
| 2022Q1 | 14.74 | 111.19 | -0.98 | -26,811 | -24 | |
| 2021Q4 | 13.23 | 118.76 | -0.92 | -26,684 | -22 | |
| 2021Q3 | 17.45 | 120.12 | -0.8 | -23,602 | -20 | |
| 2021Q2 | 23.96 | 121.15 | -0.66 | -19,516 | -16 | |
| 2021Q1 | 25.69 | 120.63 | -0.67 | -18,042 | -15 | |
| 2020Q4 | 18.99 | 125.97 | -0.56 | -12,656 | -10 |